Q2 2026 13F · SEC CIK 1230765

Rice Hall James & Associates, LLC

Asset managerFiled 2026-08-07 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value: $2.1B
Reported positions: 240
Top holdings a year, 3 yrs: +20.8%
Assets under management: $1.7B

Rice Hall James & Associates, LLC is an asset manager that reported 240 positions worth $2.1B in its Q2 2026 13F, filed 2026-08-07. Its largest holdings were Ligand Pharmaceuticals Inc (LGND, 4.2%), ACI Worldwide Inc (ACIW, 2.5%), Arlo Technologies Inc Com (ARLO, 2.4%). A portfolio copying its top holdings returned 20.8% a year over the last 3 years, against 20.4% for the S&P 500.

Rice Hall James & Associates, LLC holdings largest 50 of 240 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Rice Hall James & Associates, LLC 13F holdings
Stock	% of 13F value	Q1 2026	Shares	Share change	Reported value
LGNDLigand Pharmaceuticals Inc	4.2%	3.2%	270,052	-4.8%	$85.4M
ACIWACI Worldwide Inc	2.5%	2.3%	1,006,595	+0.3%	$50.6M
ARLOArlo Technologies Inc Com	2.4%	2.9%	3,732,962	+2.0%	$50.3M
FNFabrinet	2.4%	3.1%	87,577	-17.2%	$49.2M
ESTAEstablishment Labs Hldgs Inc	2.3%	1.7%	560,935	+2.2%	$48.1M
XPOXpo Inc	2.2%	2.4%	224,878	+0.3%	$46.2M
JCOMZiff Davis Inc	2.1%	1.9%	821,496	+2.7%	$43.0M
FOURShift4 Pmts Inc Cl A	2.1%	2.1%	874,492	+3.2%	$42.5M
KNSAKiniksa Pharmaceuticals Intl	1.9%	1.6%	624,928	+2.7%	$40.0M
ASNDAscendis Pharma A/s	1.9%	—	148,644	—	$39.6M
LRNStride Inc	1.8%	2.2%	438,981	+0.1%	$37.9M
PBHPrestige Consumer Health	1.6%	1.7%	689,692	+32.2%	$32.6M
DFINDonnelley Financial Solutions	1.6%	2.0%	775,119	-0.6%	$32.5M
ITRNIturan Location and Control	1.4%	1.5%	475,496	-10.6%	$29.0M
MEDPMedpace Hldgs Inc	1.4%	1.4%	54,116	+0.2%	$28.7M
AWIArmstrong World Inds Inc New	1.4%	1.6%	177,147	+0.2%	$28.4M
GDDYGodaddy Inc	1.4%	1.5%	330,474	+3.4%	$28.1M
BIRKBirkenstock Holding PLC	1.3%	1.2%	629,868	+6.7%	$27.1M
YOUClear Secure Inc	1.3%	1.6%	485,011	-16.0%	$27.0M
NGVTIngevity Corp	1.3%	1.4%	351,203	+1.8%	$26.2M
WEXWex Inc	1.2%	1.5%	178,606	-0.9%	$25.2M
SRADSportradar Group AG	1.2%	1.5%	1,597,682	+1.0%	$23.9M
LQDTLiquidity Svcs Inc	1.2%	1.0%	608,476	+1.9%	$23.8M
AGMFederal Agric Mtg Corp	1.1%	0.9%	118,094	+3.0%	$23.5M
BCRXBiocryst Pharmaceuticals Inc	1.1%	1.2%	2,332,043	+4.6%	$23.3M
UPWKUpwork Inc	1.1%	0.8%	2,776,805	+112.3%	$23.2M
GGenpact Limited	1.1%	1.5%	833,996	+18.4%	$22.9M
SUPNSupernus Pharmaceuticals	1.1%	1.4%	490,221	+2.7%	$22.8M
VRDNViridian Therapeutics Inc	1.1%	1.0%	1,175,906	+30.9%	$21.6M
RDWRRadware Ltd	1.0%	1.0%	680,853	-0.4%	$21.0M
ALKSAlkermes PLC	1.0%	0.8%	390,866	+0.1%	$20.5M
NEXNNexxen Intl Ltd	1.0%	0.8%	2,186,838	+3.3%	$19.7M
PRGSProgress Software Corp	0.9%	—	570,261	—	$19.1M
QDELQuidelortho Corp	0.9%	0.9%	1,063,559	+3.6%	$18.6M
LMATLemaitre Vascular Inc	0.9%	1.1%	189,907	+2.8%	$18.2M
EEFTEuronet Worldwide Inc	0.9%	0.9%	247,689	+2.4%	$18.1M
LKQLkq Corp	0.9%	1.1%	678,259	-1.0%	$17.9M
WIXWix Com Ltd	0.8%	1.5%	382,619	+28.9%	$17.4M
NBIXNeurocrine Biosciences Inc	0.8%	0.7%	100,195	+0.2%	$16.9M
HROWHarrow Inc	0.8%	0.7%	387,545	+5.3%	$16.5M
OSKOshkosh Corp	0.8%	—	106,011	—	$16.3M
MTNVail Resorts Inc	0.8%	0.8%	117,085	+0.3%	$15.9M
ACADAcadia Pharmaceuticals Inc	0.8%	0.8%	618,887	+0.2%	$15.7M
LCIILci Inds	0.7%	0.7%	142,665	+35.4%	$15.1M
VREXVarex Imaging Corp	0.7%	0.8%	1,445,853	+13.4%	$15.1M
MMSMaximus Inc	0.7%	0.8%	278,910	+25.1%	$15.0M
BMRNBiomarin Pharmaceutical Inc	0.7%	—	248,224	—	$14.2M
TSHATaysha Gene Therapies Inc	0.7%	—	1,992,229	—	$13.6M
OZKBank Ozk Little Rock Ark Com	0.7%	0.7%	259,433	-0.1%	$13.5M
MIRMMirum Pharmaceuticals Inc	0.6%	0.8%	110,673	-24.7%	$13.0M

What Rice Hall James & Associates, LLC bought and sold in Q2 2026, against Q1 2026.

New positions

Q1 2026's filing was too long to tell new positions apart.

Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.

How the holdings did against the S&P 500.

1 year: +9.8% /yr; S&P 500 +20.1%
3 years: +20.8% /yr; S&P 500 +20.4%
5 years: +7.7% /yr; S&P 500 +11.6%

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter	13F value	Positions
Q2 2026	$2.1B	240
Q1 2026	$1.8B	243
Q4 2025	$1.8B	243
Q3 2025	$1.8B	248
Q2 2025	$1.9B	247
Q1 2025	$1.7B	248
Q4 2024	$1.8B	249
Q3 2024	$1.8B	250
Q2 2024	$1.7B	256
Q1 2024	$1.8B	257
Q4 2023	$1.7B	260
Q3 2023	$1.6B	260

Questions about Rice Hall James & Associates, LLC's portfolio

What stocks does Rice Hall James & Associates, LLC own?

Rice Hall James & Associates, LLC's latest 13F, for Q2 2026 and filed Aug 7, 2026, lists 240 positions worth $2.1B. The largest are Ligand Pharmaceuticals Inc (LGND) at 4.2%, ACI Worldwide Inc (ACIW) at 2.5%, Arlo Technologies Inc Com (ARLO) at 2.4%, Fabrinet (FN) at 2.4% and Establishment Labs Hldgs Inc (ESTA) at 2.3%.

What did Rice Hall James & Associates, LLC buy last quarter?

In Q2 2026, Rice Hall James & Associates, LLC added Upwork Inc (UPWK) (+112.3% shares), Lci Inds (LCII) (+35.4% shares) and Prestige Consumer Health (PBH) (+32.2% shares), compared with its Q1 2026 filing.

What did Rice Hall James & Associates, LLC sell last quarter?

In Q2 2026, Rice Hall James & Associates, LLC cut from its top 50 Ascendis Pharma A/s, cut from its top 50 Amdocs Ltd (DOX), cut from its top 50 Chart Inds Inc (GTLS), cut from its top 50 CRA Intl Inc (CRAI), cut from its top 50 Shutterstock Inc (SSTK), Mirum Pharmaceuticals Inc (MIRM) (-24.7% shares), Fabrinet (FN) (-17.2% shares) and Clear Secure Inc (YOU) (-16.0% shares), compared with its Q1 2026 filing.

How has Rice Hall James & Associates, LLC's portfolio performed?

A portfolio copying Rice Hall James & Associates, LLC's 20 largest 13F holdings each quarter, from the day each filing was public, returned +20.8% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +9.8% against +20.1%. Over 5 years: +7.7% a year against +11.6%.

When is Rice Hall James & Associates, LLC's next 13F filing due?

13F filings are due 45 days after each quarter ends. Rice Hall James & Associates, LLC's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.

How much money does Rice Hall James & Associates, LLC manage?

Rice Hall James & Associates, LLC reported $1.7B of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $2.1B.